Alcon Announces Third Quarter 2004 Financial Results Release And Conference Call Dates
10/19/2005 5:11:46 PM
More...
|
Allergan Inc. (AGN) Files Suit Against Alcon For Patent Infringement
10/19/2005 5:11:41 PM
More...
|
Alcon Receives Approvable Letter For EXTRAVAN (TM)
10/19/2005 5:11:29 PM
More...
|
Alcon Presents RETAANE 15mg Depot Clinical Update At Association For Research And Vision In Ophthalmology Annual Meeting
10/19/2005 5:11:28 PM
More...
|
Alcon's Second Quarter Earnings Rise 67.9 Percent On 12.3 Percent Sales Growth
10/19/2005 5:11:21 PM
More...
|
Tim Sear To Retire As Alcon President, CEO
10/19/2005 5:11:12 PM
More...
|
Alcon Receives FDA Approval For A Supplemental List Of Susceptible Pathogens For VIGAMOX Ophthalmic Solution
10/19/2005 5:11:03 PM
More...
|
Company Profile For Alcon
10/19/2005 5:11:01 PM
More...
|
Alcon Release: New Investigational Treatment For Vision Loss Shows Promise
10/19/2005 5:10:48 PM
More...
|
Alcon To Initiate New Anecortave Acetate Clinical Trials For Age-Related Macular Degeneration
10/19/2005 5:10:46 PM
More...
|
|